Mechanistic interplay between ceramide and insulin resistance

Recent research adds to a growing body of literature on the essential role of ceramides in glucose homeostasis and insulin signaling, while the mechanistic interplay between various components of ceramide metabolism remains to be quantified. We present an extended model of C16:0 ceramide production through both the de novo synthesis and the salvage pathways. We verify our model with a combination of published models and independent experimental data. In silico experiments of the behavior of ceramide and related bioactive lipids in accordance with the observed transcriptomic changes in obese/diabetic murine macrophages at 5 and 16 weeks support the observation of insulin resistance only at the later phase. Our analysis suggests the pivotal role of ceramide synthase, serine palmitoyltransferase and dihydroceramide desaturase involved in the de novo synthesis and the salvage pathways in influencing insulin resistance versus its regulation.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  F. Liu,et al.  Regulation of Insulin Action by Ceramide , 2004, Journal of Biological Chemistry.

[3]  S. Grosskurth,et al.  Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expression[S] , 2012, Journal of Lipid Research.

[4]  David Montaner,et al.  Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice , 2011, Diabetes.

[5]  A. Gomez-Muñoz.  Ceramide 1-phosphate/ceramide, a switch between life and death. , 2006, Biochimica et biophysica acta.

[6]  Alfred H. Merrill,et al.  Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.

[7]  Ying Sun,et al.  Identification of Type 2 Diabetes Genes in Mexican Americans Through Genome-Wide Association Studies , 2007, Diabetes.

[8]  Corrado Priami,et al.  Analysis of Biological Systems , 2015 .

[9]  Y. Hannun,et al.  Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism[S] , 2011, Journal of Lipid Research.

[10]  Wei Hu,et al.  Differential Regulation of Dihydroceramide Desaturase by Palmitate versus Monounsaturated Fatty Acids , 2011, The Journal of Biological Chemistry.

[11]  M. D'Andrea,et al.  Characterization of Serine Palmitoyltransferase in Normal Human Tissues , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  D. Muoio,et al.  Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption , 2010, Diabetes.

[13]  M. Cabot,et al.  Ceramide-based therapeutics for the treatment of cancer. , 2011, Anti-cancer agents in medicinal chemistry.

[14]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[15]  Mano Ram Maurya,et al.  Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism , 2011, BMC Systems Biology.

[16]  B. Kleuser,et al.  Divergent Role of Sphingosine 1-Phosphate on Insulin Resistance , 2014, Cellular Physiology and Biochemistry.

[17]  Shankar Subramaniam,et al.  Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4 Published, JLR Papers in Press, February 14, 2006. , 2006, Journal of Lipid Research.

[18]  M. Birnbaum,et al.  Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.

[19]  J. Ussher,et al.  Targeting ceramide metabolism in obesity. , 2016, American journal of physiology. Endocrinology and metabolism.

[20]  Anna Gambin,et al.  Computational modeling of sphingolipid metabolism , 2015, BMC Systems Biology.

[21]  Alex Doney,et al.  Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge , 2010, Nature Genetics.

[22]  Josée Dupuis,et al.  A 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study , 2007, Diabetes.

[23]  N. Ferreirós,et al.  The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS. , 2013, The international journal of biochemistry & cell biology.

[24]  Paulo Mazzafera,et al.  An Arabidopsis Mitochondrial Uncoupling Protein Confers Tolerance to Drought and Salt Stress in Transgenic Tobacco Plants , 2011, PloS one.

[25]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[26]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[27]  J. Pankow,et al.  Genome-Wide Detection of Allele Specific Copy Number Variation Associated with Insulin Resistance in African Americans from the HyperGEN Study , 2011, PloS one.

[28]  D. Gillespie.  A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions , 1976 .

[29]  G. Shulman,et al.  Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity* , 2015, The Journal of Biological Chemistry.

[30]  V. Shahrezaei,et al.  The stochastic nature of biochemical networks. , 2008, Current opinion in biotechnology.

[31]  Y. Hannun,et al.  The sphingolipid salvage pathway in ceramide metabolism and signaling. , 2008, Cellular signalling.

[32]  Corrado Priami,et al.  A Rule-Based and Imperative Language for Biochemical Modeling and Simulation , 2012, SEFM.

[33]  Matthias Blüher,et al.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. , 2014, Cell metabolism.

[34]  S. Summers,et al.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.

[35]  Gh. Adam,et al.  A first-order perturbative numerical method for the solution of the radial schrödinger equation , 1976 .

[36]  S. Morad,et al.  Gaucher's disease and cancer: a sphingolipid perspective. , 2013, Critical reviews in oncogenesis.

[37]  Eoin Fahy,et al.  A Mouse Macrophage Lipidome*♦ , 2010, The Journal of Biological Chemistry.

[38]  I. Kowalska,et al.  The role of skeletal muscle sphingolipids in the development of insulin resistance. , 2008, The review of diabetic studies : RDS.

[39]  S. Morad,et al.  Ceramide-orchestrated signalling in cancer cells , 2012, Nature Reviews Cancer.